Technology
Health
Pharmaceutical

Tricida

$32.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.30 (-3.83%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Tricida and other stocks, options, ETFs, and crypto commission-free!

About TCDA

Tricida, Inc. Common Stock, also called Tricida, is a pharmaceutical company, which focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. Read More The company was founded by Gerrit Klaerner and Craig Jon Hawker in 2013 and is headquartered in South San Francisco, CA.

Employees
76
Headquarters
South San Francisco, California
Founded
2013
Market Cap
1.45B
Price-Earnings Ratio
Dividend Yield
Average Volume
175.26K
High Today
$34.18
Low Today
$32.07
Open Price
$33.50
Volume
210.71K
52 Week High
$42.80
52 Week Low
$19.43

Collections

Technology
Health
Pharmaceutical
2018 IPO
US
North America

TCDA Earnings

-$0.89
-$0.79
-$0.70
-$0.60
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.